Abstract
Excretion of creatine, creatinine, and 4-amino-5-imidazolecarboxamide (AIC) was studied in genetically determined muscular dystrophy in the human and mouse. The AIC excretion was normal in both affected humans and mice as compared with groups of comparably aged controls. The creatine-to-creatinine ratio for human muscular dystrophics was more than four times as great as for their unaffected siblings. Both normal and dystrophic mice showed a "creatinuria" as compared to humans. The creatine-to-creatinine ratio for dystrophic mice was significantly higher than the controls, but the difference was apparent only in the first 2 months of life.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
